share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 28 17:09
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 2,465 shares of common stock on February 28, 2024, according to a recent filing. The shares, valued at an aggregate market value of $26,129, were acquired by Watanabe on February 27, 2024, through the vesting of restricted stock directly from Arcutis Biotherapeutics. This transaction follows a period where no other sales were reported by Watanabe in the past three months.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 2,465 shares of common stock on February 28, 2024, according to a recent filing. The shares, valued at an aggregate market value of $26,129, were acquired by Watanabe on February 27, 2024, through the vesting of restricted stock directly from Arcutis Biotherapeutics. This transaction follows a period where no other sales were reported by Watanabe in the past three months.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more